SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-028670
Filing Date
2021-05-18
Accepted
2021-05-18 15:11:38
Documents
20
Period of Report
2021-05-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ovid-8k_20210518.htm 8-K 30746
2 EX-99.1 ovid-ex991_35.htm EX-99.1 19266
3 GRAPHIC slide-i2oyvvzuutj.jpg GRAPHIC 232594
4 GRAPHIC slide-vd0rcu4cior.jpg GRAPHIC 219811
5 GRAPHIC slide-tcimtqfluco.jpg GRAPHIC 450306
6 GRAPHIC slide-20zgxucztvq.jpg GRAPHIC 224818
7 GRAPHIC slide-qkjwkqexomn.jpg GRAPHIC 209321
8 GRAPHIC slide-mo1r3tk5xtp.jpg GRAPHIC 223006
9 GRAPHIC slide-rrnu1bdqjly.jpg GRAPHIC 267148
10 GRAPHIC slide-v32qlugjagq.jpg GRAPHIC 252230
11 GRAPHIC slide-i1oufocdlpu.jpg GRAPHIC 155889
12 GRAPHIC slide-n0b3mwkb2nd.jpg GRAPHIC 276670
13 GRAPHIC slide-1fhbqduaehz.jpg GRAPHIC 225779
14 GRAPHIC slide-wyvdzbo2bia.jpg GRAPHIC 216122
15 GRAPHIC slide-pbqpw4pmdaa.jpg GRAPHIC 168355
16 GRAPHIC slide-trz0ijgv3wu.jpg GRAPHIC 158101
17 GRAPHIC slide-5ym54gynkrd.jpg GRAPHIC 158837
18 GRAPHIC slide-oqshbfsddtj.jpg GRAPHIC 220787
19 GRAPHIC slide-hxoi0gmmdht.jpg GRAPHIC 228875
20 GRAPHIC slide-x4u1i4t0fol.jpg GRAPHIC 151568
  Complete submission text file 0001564590-21-028670.txt   5618066
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38085 | Film No.: 21935709
SIC: 2834 Pharmaceutical Preparations